Citation Select	Nicolau AM, Giugliano RP, Zimerman A, Afilalo J, Gencer B, Steffel J, Palazzolo MG, Eikelboom JW, Granger CB, Patel MR, Lopes RD, Gersh BJ, Suleiman B, de Groot JR, Scanavacca MI, Ruff CT, Antman EM, Braunwald E, Wallentin L Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin: The COMBINE-AF Substudy J Am Coll Cardiol. 2025 Aug 12;86(6):426-439. doi: 10.1016/j.jacc.2025.05.060
Citation Select	ALONE-AF Investigators; Kim D, Shim J, Choi EK, Oh IY, Kim J, Lee YS, Park J, Ko JS, Park KM, Sung JH, Park HW, Park HS, Kim JY, Kang KW, Kim D, Park JK, Kim DH, Kim JB, Yu HT, Kim TH, Uhm JS, Pak HN, Joung B Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial JAMA. 2025 Aug 31. doi: 10.1001/jama.2025.14679. Epub ahead of print
Citation Select	Montané B, Zhang S, Wolfe JD, Prime S, Luo C, Cooper DH, Doering M, Blomstrom-Lundqvist C, Nashef SAM, Osmancik P, Andrade JG, Bertaglia E, Parkash R, Mark DB, Nielsen JC, Sharples LD, Gage BF Catheter and Surgical Ablation for Atrial Fibrillation : A Systematic Review and Meta-analysis Ann Intern Med. 2025 Jul 1. doi: 10.7326/ANNALS-25-00253. Epub ahead of print
Citation Select	McCabe JJ, Cheung Y, Foley M, Brennan SO, Buckley J, Renom PC, Cassidy T,Collins R, Dolan E, Grosse GM, Harbison J, James K, Khadjooi K, Induruwa I, Katan M, Maher S, O,Connor M, O,Donnell M, Purroy F, Synott P, Kelly PJ Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis JAMA Neurol. 2025 May 21:e251337. doi: 10.1001/jamaneurol.2025.1337. Epub ahead of print
Citation Select	Pamporis K, Karakasis P, Sagris M, Theofilis P, Milaras N, Pantelidaki A, Mourouzis I, Fragakis N, Vlachos K, Kordalis A, Tsiachris D Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis Eur J Prev Cardiol. 2025 Mar 7:zwaf138. doi: 10.1093/eurjpc/zwaf138
Citation Select	Kemp Gudmundsdottir K, Svennberg E, Friberg L, Hygrell T, Frykman V, Al- Khalili F, Hijazi Z, Rosenqvist M, Engdahl J Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year-Olds to Detect Atrial Fibrillation: STROKESTOP II Circulation. 2024 Dec 3;150(23):1837-1846. doi: 10.1161/CIRCULATIONAHA.124.071176
Citation Select	Lopes RD, Granger CB, Wojdyla DM, McIntyre WF, Alings M, Mani T, Ramasundarahettige C, Rivard L, Atar D, Birnie DH, Boriani G, Amit G, Leong-Sit P, Rinne C, Duray GZ, Gold MR, Hohnloser SH, Kutyifa V, Benezet-Mazuecos J, Cosedis Nielsen J, Sticherling C, Benz AP, Linde C, Kautzner J, Mabo P, Mairesse GH, Connolly SJ, Healey JS Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA J Am Coll Cardiol. 2024 Jul 23;84(4):354-364. doi: 10.1016/j.jacc.2024.05.002
Citation Select	ARTESIA Investigators; Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling C, Wong JA, Wright DJ, Zarraga IG, Coutts SB, Kaplan A, Pombo M, Ayala-Paredes F, Xu L, Simek K, Nevills S, Mian R, Connolly SJ Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234
Citation Select	Ullah W, Johnson D, Nair AS, Dikdan SJ, Frankel E, Humayun W, Pavri BB, Frisch D Ablation Versus Antiarrhythmic Drugs as First-Line Therapy for Treatment-Naive Atrial Fibrillation: A Systematic Review and Meta-Analysis Am J Cardiol. 2023 Nov 30;213:63-68. doi: 10.1016/j.amjcard.2023.11.052
Citation Select	NOAH-AFNET 6 Investigators; Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N, Bertaglia E, Blomstrom Lundqvist C, Borlich M, Brandes A, Cabanelas N, Calvert M, Chlouverakis G, Dan GA, de Groot JR, Dichtl W, Kravchuk B, Lubiński A, Marijon E, Merkely B, Mont L, Ozga AK, Rajappan K, Sarkozy A, Scherr D, Sznajder R, Velchev V, Wichterle D, Sehner S, Simantirakis E, Lip GYH, Vardas P, Schotten U, Zapf A Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes N Engl J Med. 2023 Sep 28;389(13):1167-1179. doi: 10.1056/NEJMoa2303062
Citation Select	RENAL-AF Investigators; Pokorney SD, Chertow GM, Al-Khalidi HR, Gallup D, Dignacco P, Mussina K, Bansal N, Gadegbeku CA, Garcia DA, Garonzik S, Lopes RD, Mahaffey KW, Matsuda K, Middleton JP, Rymer JA, Sands GH, Thadhani R, Thomas KL, Washam JB, Winkelmayer WC, Granger CB Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial Circulation. 2022 Dec 6;146(23):1735-1745. doi: 10.1161/CIRCULATIONAHA.121.054990
Citation Select	EARLY-AF Investigators; Andrade JG, Deyell MW, Macle L, Wells GA, Bennett M, Essebag V, Champagne J, Roux JF, Yung D, Skanes A, Khaykin Y, Morillo C, Jolly U, Novak P, Lockwood E, Amit G, Angaran P, Sapp J, Wardell S, Lauck S, Cadrin-Tourigny J, Kochhäuser S, Verma A Progression of Atrial Fibrillation after Cryoablation or Drug Therapy N Engl J Med. 2022 Nov 7. doi: 10.1056/NEJMoa2212540
Citation Select	Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, A A Fox K, Gencer B, Halperin JL, Hijazi Z, Hohnloser SH, Hua K, Hylek E, Toda Kato E, Kuder J, Lopes RD, Mahaffey KW, Oldgren J, Piccini JP, Ruff CT, Steffel J, Wojdyla D, Granger CB; COMBINE AF Investigators Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex Circulation. 2022 Jan 25;145(4):242-255. doi: 10.1161/CIRCULATIONAHA.121.056355
Citation Select	Svendsen JH, Diederichsen SZ, Højberg S, Krieger DW, Graff C, Kronborg C, Olesen MS, Nielsen JB, Holst AG, Brandes A, Haugan KJ, Køber L Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial Lancet. 2021 Aug 27:S0140-6736(21)01698-6. doi: 10.1016/S0140-6736(21)01698-6
Citation Select	Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial Lancet. 2021 Aug 27:S0140-6736(21)01637-8. doi: 10.1016/S0140-6736(21)01637-8
Citation Select	Oussama M Wazni, Gopi Dandamudi, Nitesh Sood, Robert Hoyt, Jaret Tyler, Sarfraz Durrani, Mark Niebauer, Kevin Makati, Blair Halperin, Andre Gauri, Gustavo Morales, Mingyuan Shao, Jeffrey Cerkvenik, Rachelle E Kaplon, Steven E Nissen, STOP AF First Trial Investigators Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation N Engl J Med. 2021 Jan 28;384(4):316-324. doi: 10.1056/NEJMoa2029554
Citation Select	Dipak Kotecha, Karina V Bunting, Simrat K Gill, Samir Mehta, Mary Stanbury, Jacqueline C Jones, Sandra Haynes, Melanie J Calvert, Jonathan J Deeks, Richard P Steeds, Victoria Y Strauss, Kazem Rahimi, A John Camm, Michael Griffith, Gregory Y H Lip, Jonathan N Townend, Paulus Kirchhof, Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Team Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial JAMA. 2020 Dec 22;324(24):2497-2508. doi: 10.1001/jama.2020.23138
Citation Select	Okumura , Akao , Yoshida , Kawata , Okazaki , Akashi , Eshima , Tanizawa , Fukuzawa , Hayashi , Akishita , Lip , Yamashita , ELDERCARE-AF Committees and Investigators Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation N Engl J Med. 2020 Aug 30. doi: 10.1056/NEJMoa2012883. [Epub ahead of print]
Citation Select	EAST-AFNET 4 Trial Investigators; Kirchhof, Camm, Goette, Brandes, Eckardt, Elvan, Fetsch, van Gelder, Haase, Haegeli, Hamann, Heidbüchel, Hindricks, Kautzner, Kuck, Mont, Ng, Rekosz, Schoen, Schotten, Suling, Taggeselle, Themistoclakis, Vettorazzi, Vardas, Wegscheider, Willems, Crijns, Breithardt Early Rhythm-Control Therapy in Patients with Atrial Fibrillation N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422
Citation Select	Randhawa MS, Vishwanath R, Rai MP, Wang L, Randhawa AK, Abela G, Dhar G Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis JAMA Netw Open. 2020 Apr 1;3(4):e202175. doi: 10.1001/jamanetworkopen.2020.2175
Citation Select	CABANA Investigators; Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial JAMA. 2019 Apr 2;321(13):1261-1274. doi: 10.1001/jama.2019.0693
Citation Select	RACE 7 ACWAS Investigators; Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, Meeder JG, Lenderink T, Widdershoven J, Bucx JJJ, Rienstra M, Kamp O, Van Opstal JM, Alings M, Oomen A, Kirchhof CJ, Van Dijk VF, Ramanna H, Liem A, Dekker LR, Essers BAB, Tijssen JGP, Van Gelder IC, Crijns HJGM Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation N Engl J Med. 2019 Mar 18. doi: 10.1056/NEJMoa1900353. [Epub ahead of print]
Citation Select	Dalgaard F, Pallisgaard JL, Numé AK, Lindhardt TB, Gislason GH, Torp-Pedersen C, Ruwald MH Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope J Am Geriatr Soc. 2019 Jul 24. doi: 10.1111/jgs.16062. [Epub ahead of print]
Citation Select	Bruins Slot KM, Berge E Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation Cochrane Database Syst Rev. 2018 Mar 06;3:CD008980
Citation Select	CASTLE-AF Investigators; Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D Catheter Ablation for Atrial Fibrillation with Heart Failure N Engl J Med. 2018 02 01;378(5):417-427
Citation Select	ARISTOTLE and STABILITY Investigators; Hijazi Z, Lindbäck J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation Eur Heart J. 2016 May 21;37(20):1582-90
Citation Select	Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis Circulation. 2015 Jul 21;132(3):194-204
Citation Select	Holmes DR, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H, Valderrabano M, Reddy VY Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis J Am Coll Cardiol. 2015 Jun 23;65(24):2614-23
Citation Select	Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, ROCKET AF Steering Committee and Investigators* ROCKET AF Steering Committee and Investigators*, Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the ROCKET AF trial Circulation. 2014 Jul 8;130(2):138-46
Citation Select	Sardar P, Chatterjee S, Chaudhari S, Lip GY, New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials. J Am Geriatr Soc. 2014 May;62(5):857-64
Citation Select	ARISTOTLE Committees and Investigators, Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med. 2011 Sep 15;365(11):981-92
Citation Select	the ROCKET AF Investigators, Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation N Engl J Med. 2011 Sep 8;365(10):883-91. Epub 2011 Aug 10
Citation Select	Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial Circulation. 2011 May 31;123(21):2363-72
Citation Select	ACTIVE I Investigators, Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ Irbesartan in patients with atrial fibrillation N Engl J Med. 2011 Mar 10;364(10):928-38
Citation Select	AVERROES Steering Committee and Investigators, Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O,Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S Apixaban in Patients with Atrial Fibrillation N Engl J Med. 2011 Mar 3;364(9):806-17. Epub 2011 Feb 10
Citation Select	RACE II Investigators, Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med. 2010 Apr 15;362(15):1363-73
Citation Select	RE-LY Steering Committee and Investigators; Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med. 2009 Sep 17;361(12):1139-51. Epub 2009 Aug 30
Citation Select	ACTIVE Investigators; Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med. 2009 May 14;360(20):2066-78
Citation Select	GISSI-AF Investigators; Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, Lucci D, Di Pasquale G, Tognoni G Valsartan for prevention of recurrent atrial fibrillation N Engl J Med. 2009 Apr 16;360(16):1606-17
Citation Select	van Walraven C, Hart RG, Connolly S, Austin PC, Mant J, Hobbs FD, Koudstaal PJ, Petersen P, Perez-Gomez F, Knottnerus JA, Boode B, Ezekowitz MD, Singer DE Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators Stroke. 2009 Apr;40(4):1410-6
Citation Select	Atrial Fibrillation and Congestive Heart Failure Investigators; Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O,Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med. 2008 Jun 19;358(25):2667-77
Citation Select	Gjesdal K, Feyzi J, Olsson SB Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data Heart. 2008 Feb;94(2):191-6. Epub 2007 May 4
Citation Select	BAFTA investigators, Midland Research Practices Network (MidReC); Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet. 2007 Aug 11;370(9586):493-503
Citation Select	Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL, Packer DL, Hammill SC, Shen WK, Gersh BJ Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study Circulation. 2007 Jun 19;115(24):3050-6
Citation Select	Buckley MS, Nolan PE, Slack MK, Tisdale JE, Hilleman DE, Copeland JG, Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy. 2007 Mar;27(3):360-8
Citation Select	Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F, Santinelli V, A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol. 2006 Dec 5;48(11):2340-7
Citation Select	Budeus M, Hennersdorf M, Perings S, Rohlen S, Schnitzler S, Felix O, Reimert K, Feindt P, Gams E, Lehmann N, Wieneke H, Sack S, Erbel R, Perings C Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study Eur Heart J. 2006 Jul;27(13):1584-91. Epub 2006 Jun 7
Citation Select	ACTIVE Writing Group on behalf of the ACTIVE Investigators; Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet. 2006 Jun 10;367(9526):1903-12
Citation Select	Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahe I, Bergmann JF Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials Arch Intern Med. 2006 Apr 10;166(7):719-28
Citation Select	Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr, Bates ER, Lehmann MH, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V, Morady F Circumferential pulmonary-vein ablation for chronic atrial fibrillation N Engl J Med. 2006 Mar 2;354(9):934-41
Citation Select	Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, Turco P, Pascotto P, Fazzari M, Vitale DF Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study) Eur Heart J. 2006 Jan;27(2):216-21. Epub 2005 Oct 7
Citation Select	Aasbo JD, Lawrence AT, Krishnan K, Kim MH, Trohman RG Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis Ann Intern Med. 2005 Sep 6;143(5):327-36
Citation Select	Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial JAMA. 2005 Jun 1;293(21):2634-40
Citation Select	Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, Connolly SJ Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9
Citation Select	Testa L, Biondi-Zoccai GG, Russo AD, Bellocci F, Andreotti F, Crea F Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis Eur Heart J. 2005 Oct;26(19):2000-6. Epub 2005 May 4
Citation Select	Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study J Am Coll Cardiol. 2005 Mar 1;45(5):705-11
Citation Select	de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis Arch Intern Med. 2005 Feb 14;165(3):258-62
Citation Select	Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med. 2004 Dec 2;351(23):2373-83
Citation Select	Marshall DA, Levy AR, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Greene HL, Wyse DG, Nichol G, O,Brien BJ; AFFIRM and CORE Investigators Cost-effectiveness of rhythm versus rate control in atrial fibrillation Ann Intern Med. 2004 Nov 2;141(9):653-61
Citation Select	Crystal E, Garfinkle MS, Connolly SS, Ginger TT, Sleik K, Yusuf SS Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003611
Citation Select	Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) Study Group A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med. 2002 Dec 5;347(23):1834-40
Citation Select	The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators; Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med. 2002 Dec 5;347(23):1825-33